Point-of-care diagnostics firm LumiraDx on Tuesday reported a 65 percent decrease in its fourth quarter revenues.

In March 2023, Cygnus received another round of Series C+ financing of hundreds of millions of RMB, led by Source Capital, and followed by Jianxin Equity, Yizhuang State Investment, Fangzhenghesheng, and Hetang Venture Capital.

DiaSorin said late Friday that it has nabbed US Food and Drug Administration 510(k) clearance for a molecular assay that differentiates between infections with the SARS-CoV-2 and influenza A and B viruses.

Cue Health announced on Monday that it has received Emergency Use Authorization from the US Food and Drug Administration for its molecular monkeypox test.

On March 18th, at the 8th E-Trade Bioindustry Conference of 2023EBC, MGI Tech held the "DNBSEQ-G99 Signing Ceremony" and reached cooperation with 6 enterprise partners to develop G99-based application expansion.

Digital health company Biostarks has announced new at-home longevity test kits that leverage the firm’s mass-spectrometry platform.

Enzo Biochem said after the close of markets on Thursday that it has entered an agreement to sell the assets of its clinical laboratory division to Laboratory Corporation of America.

The February operating data of the three major airlines, China Eastern Airlines (MU), China Southern Airlines (CZ) & Air China (CA) were released.

Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.

Liquid handling instrumentation firm Integra Biosciences said that it has acquired Miroculus, a sample prep automation company that has been developing microfluidics-based platforms for next-generation sequencing.

Becton Dickinson announced that it received 510(k) clearance from the US Food and Drug Administration for a high-throughput assay to detect vaginitis.

Owlstone Medical and Bicycle Therapeutics said that the firms will collaborate on research into breath-based early cancer detection tests that would combine Bicycle's proprietary bicyclic peptides with Owlstone's exogenous volatile organic compound probes.

Cue Health Inc., a healthcare technology company, reported financial results for the fourth quarter and full-year 2022.

On March 14, 2023, Agilent Technologies announced the establishment of an innovation collaboration lab with Alta Scientific Co., Ltd.

Oxford Gene Technology announced that eight of its CytoCell fluorescence in situ hybridization probes have been certified for clinical use in line with Europe's In Vitro Diagnostics Regulation (IVDR).